Digoxigenin modification of adenovirus to spatially control gene delivery from chitosan surfaces

Journal of Controlled Release

Volumn 135, Issue 3, 2009, Pages 250-258

  Hu, Wei Wen ^a   Lang, Michael W ^a   Krebsbach, Paul H ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Adenovirus; Antibody; Digoxigenin; Gene delivery; Tissue engineering

Indexed keywords

ADENOVIRUS; ANTIBODY IMMOBILIZATIONS; BIOMATERIAL SCAFFOLDS; CAPSID PROTEINS; CELL SIGNALING; CHITOSAN FILMS; CONTROL TISSUES; DELIVERY SYSTEMS; DIGOXIGENIN; DISCRETE REGIONS; FLUORESCENT PROTEINS; GENE DELIVERY; IN-VIVO; REPORTER GENES; SURFACE MODIFICATIONS; VIRAL INFECTIVITIES; VIRAL VECTORS;

BIOLOGICAL MATERIALS; BIOMATERIALS; CELL CULTURE; CHITIN; CHITOSAN; GENE TRANSFER; SUGARS; SURFACES; TISSUE ENGINEERING; TOXICITY;

ANTIBODIES;

ADENOSINE TRIPHOSPHATASE; ADENOVIRUS VECTOR; ANTIBODY CONJUGATE; BETA GALACTOSIDASE; CAPSID PROTEIN; CHITOSAN; DIGOXIGENIN; DIGOXIN; OUABAIN; VIRUS ANTIBODY;

ADENOVIRUS; ANTIBODY SPECIFICITY; ARTICLE; BIOFILM; CHEMICAL MODIFICATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG CONJUGATION; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMOBILIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTIVITY;

ADENOVIRIDAE; ANTIBODIES, IMMOBILIZED; ANTIBODIES, VIRAL; CAPSID PROTEINS; CHITOSAN; COATED MATERIALS, BIOCOMPATIBLE; DIGOXIGENIN; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MODELS, GENETIC; TIME FACTORS; TISSUE SCAFFOLDS; TRANSDUCTION, GENETIC;

EID: 63649139973     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.01.020     Document Type: Article

References (39)

1. Sheridan M.H., Shea L.D., Peters M.C., and Mooney D.J. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. Journal of Controlled Release 64 1-3 (2000) 91-102
2. Yao F., and Eriksson E. Gene therapy in wound repair and regeneration. Wound Repair and Regeneration 8 6 (2000) 443-451
3. Holland T.A., Tabata Y., and Mikos A.G. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. Journal of Controlled Release 101 1-3 (2005) 111-125
4. Huang Y.C., Kaigler D., Rice K.G., Krebsbach P.H., and Mooney D.J. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. Journal of Bone and Mineral Research 20 5 (2005) 848-857
5. Sohier J., Vlugt T.J.H., Cabrol N., Van Blitterswijk C., de Groot K., and Bezemer J.M. Dual release of proteins from porous polymeric scaffolds. Journal of Controlled Release 111 1-2 (2006) 95-106
6. Jang J.H., Houchin T.L., and Shea L.D. Gene delivery from polymer scaffolds for tissue engineering. Expert Reviews in Medical Devices 1 1 (2004) 127-138
7. Bengali Z., and Shea L.D. Gene delivery by immobilization to cell-adhesive substrates. MRS Bulletin 30 9 (2005) 659-662
8. Alden T.D., Beres E.J., Laurent J.S., Engh J.A., Das S., London S.D., Jane Jr. J.A., Hudson S.B., and Helm G.A. The use of bone morphogenetic protein gene therapy in craniofacial bone repair. Journal of Craniofacial Surgery 11 1 (2000) 24-30
9. Ashinoff R.L., Cetrulo C.L., Galiano R.D., Dobryansky M., Bhatt K.A., Ceradini D.J., Michaels J., McCarthy J.G., and Gurtner G.C. Bone morphogenic protein-2 gene therapy for mandibular distraction osteogenesis. Annals of Plastic Surgery 52 6 (2004) 585-591
10. Lindsey W.H. Osseous tissue engineering with gene therapy for facial bone reconstruction. Laryngoscope 111 7 (2001) 1128-1136
11. Zhang Y., Song J., Shi B., Wang Y., Chen X., Huang C., Yang X., Xu D., Cheng X., and Chen X. Combination of scaffold and adenovirus vectors expressing bone morphogenetic protein-7 for alveolar bone regeneration at dental implant defects. Biomaterials 28 31 (2007) 4635-4642
12. Qiang B., Segev A., Beliard I., Nili N., Strauss B.H., and Sefton M.V. Poly(methylidene malonate 2.1.2) nanoparticles: a biocompatible polymer that enhances peri-adventitial adenoviral gene delivery. Journal of Controlled Release 98 3 (2004) 447-455
13. Wieland J.A., Houchin-Ray T.L., and Shea L.D. Non-viral vector delivery from PEG-hyaluronic acid hydrogels. Journal of Controlled Release 120 3 (2007) 233-241
14. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 286 5448 (1999) 2244-2245
15. Grossman P.M., Han Z.G., Palasis M., Barry J.J., and Lederman R.J. Incomplete retention after direct myocardial injection. Catheterization and Cardiovascular Interventions 55 3 (2002) 392-397
16. Hu W.W., Wang Z., Hollister S.J., and Krebsbach P.H. Localized viral vector delivery to enhance in situ regenerative gene therapy. Gene Therapy 14 11 (2007) 891-901
17. Hu W.W., Lang M.W., and Krebsbach P.H. Development of adenovirus immobilization strategies for in situ gene therapy. Journal of Gene Medicine 10 10 (2008) 1102-1112
18. Klugherz B.D., Song C., DeFelice S., Cui X., Lu Z., Connolly J., Hinson J.T., Wilensky R.L., and Levy R.J. Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus. Human Gene Therapy 13 3 (2002) 443-454
19. Abrahams J.M., Song C., DeFelice S., Grady M.S., Diamond S.L., and Levy R.J. Endovascular microcoil gene delivery using immobilized anti-adenovirus antibody for vector tethering. Stroke 33 5 (2002) 1376-1382
20. Fishbein I., Alferiev I.S., Nyanguile O., Gaster R., Vohs J.M., Wong G.S., Felderman H., Chen I.W., Choi H., Wilensky R.L., and Levy R.J. Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents. Proceedings of the National Academy of Sciences of the United States of America 103 1 (2006) 159-164
21. Fishbein I., Stachelek S.J., Connolly J.M., Wilensky R.L., Alferiev I., and Levy R.J. Site specific gene delivery in the cardiovascular system. Journal of Controlled Release 109 1-3 (2005) 37-48
22. Stachelek S.J., Song C., Alferiev I., Defelice S., Cui X., Connolly J.M., Bianco R.W., and Levy R.J. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants. Gene Therapy 11 1 (2004) 15-24
23. Gifford S.C., Yoshida T., Shevkoplyas S.S., and Bitensky M.W. A high-resolution, double-labeling method for the study of in vivo red blood cell aging. Transfusion 46 4 (2006) 578-588
24. Tepper O.M., and Mehrara B.J. Gene therapy in plastic surgery. Plastic and Reconstructive Surgery 109 2 (2002) 716-734
25. Suh J.K., and Matthew H.W. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials 21 24 (2000) 2589-2598
26. Soldin S.J. Digoxin-issues and controversies. Clinical Chemistry 32 1 Pt 1 (1986) 5-12
27. Smith T.W., and Haber E. Digitalis. I. New England Journal of Medicine 289 18 (1973) 945-952
28. Chan E.L., and Swaminathan R. A rapid assay for the measurement of Na+,K(+)-ATPase inhibitors. Clinical Biochemistry 25 1 (1992) 15-19
29. Chen R.R., Silva E.A., Yuen W.W., and Mooney D.J. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharmaceutical Research 24 2 (2007) 258-264
30. Richardson T.P., Peters M.C., Ennett A.B., and Mooney D.J. Polymeric system for dual growth factor delivery. Nature Biotechnology 19 11 (2001) 1029-1034
31. Hao X.J., Silva E.A., Mansson-Broberg A., Grinnemo K.H., Siddiqui A.J., Dellgren G., Wardell E., Brodin L.A., Mooney D.J., and Sylven C. Angiogenic effects of sequential release of VEGF-A(165) and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovascular Research 75 1 (2007) 178-185
32. Segura T., Volk M.J., and Shea L.D. Substrate-mediated DNA delivery: role of the cationic polymer structure and extent of modification. Journal of Controlled Release 93 1 (2003) 69-84
33. Hobson D.A., Pandori M.W., and Sano T. In situ transduction of target cells on solid surfaces by immobilized viral vectors. BMC Biotechnology 3 (2003) 4
34. Patel Z.S., and Mikos A.G. Angiogenesis with biomaterial-based drug- and cell-delivery systems. Journal of Biomaterials Science. Polymer Ed. 15 6 (2004) 701-726
35. Kaigler D., Wang Z., Horger K., Mooney D.J., and Krebsbach P.H. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. Journal of Bone and Mineral Research 21 5 (2006) 735-744
36. Bessa P.C., Casal M., and Reis R.L. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). Journal of Tissue Engineering and Regenerative Medicine 2 2-3 (2008) 81-96
37. Peng H., Usas A., Hannallah D., Olshanski A., Cooper G.M., and Huard J. Noggin improves bone healing elicited by muscle stem cells expressing inducible BMP4. Molecular Therapy 12 2 (2005) 239-246
38. Spalazzi J.P., Dagher E., Doty S.B., Guo X.E., Rodeo S.A., and Lu H.H. In vivo evaluation of a multiphased scaffold designed for orthopaedic interface tissue engineering and soft tissue-to-bone integration. Journal of Biomedical Materials Research Part A 86A 1 (2008) 1-12
39. Schek R.M., Taboas J.M., Segvich S.J., Hollister S.J., and Krebsbach P.H. Engineered osteochondral grafts using biphasic composite solid free-form fabricated scaffolds. Tissue Engineering 10 9-10 (2004) 1376-1385